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Abstract: 
Objectives: To estimate the cumulative incidence of arthritis-induced orofacial symptoms, 
dysfunctions, and dentofacial deformities in growing individuals  with juvenile idiopathic 
arthritis (JIA) in a 36 month regional cohort study, and to identify predictors for the 
development of arthritis-induced dentofacial deformities. 
Methods: Data was retrieved from the Aarhus JIA TMJ cohort register, which contains 
standardized, longitudinal, observational data regarding orofacial conditions in patients with 
JIA (n=1040). This regional cohort represents the majority of all subjects with JIA from the 
western part of Denmark between 1990 and 2016, regardless of temporomandibular joint 
(TMJ) arthritis status. Cumulative incidences of orofacial conditions were reported using 
Kaplan-Meier methods and predictors for dentofacial deformity was identified using Cox 
proportional hazard analysis.  
Results: Follow-up data from 351 subjects over thirty-six months was included in this study. 
Median age at first clinical examination was 6.6 years (25/75 centiles: 4.9 and 9.9 years). 
Orofacial symptoms and dysfunction were common findings at 36 months after the first 
clinical examination and approximately five years after JIA onset, with a cumulative 
incidence of 38% and 53%, respectively. Dentofacial deformities were found in 35% of 
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subjects at the 36-month follow-up, and were significantly associated with the presence of 
orofacial dysfunction. 
Conclusions: Orofacial conditions were frequent findings in JIA and were represented in all 
JIA subcategories in this regional study. One third of subjects had arthritis-induced 
dentofacial deformities requiring orthopedic appliance treatment at the 36-month follow-
up. 
Significance and Innovation 
 Orofacial symptoms was reported in 38 percent of the cohort and orofacial 
dysfunctions occurred in 56 percent of the cohort early in the JIA disease course. 
 Arthritis-induced dentofacial deformity was diagnosed in 35 percent of skeletally 
immature subjects early in the JIA disease course and occurred in almost all JIA 
subcategories.  
 The development of arthritis-induced dentofacial deformity was significantly 
associated with the presence of orofacial dysfunction. 
 
Temporomandibular joint (TMJ) arthritis is a recognized feature of juvenile idiopathic 
arthritis (JIA), and TMJ involvement is seen in a substantial number of patients with JIA [1-4]. 
TMJ involvement can cause joint degeneration and hamper mobility and masticatory 
function, potentially leading to asymmetric loading of joints and muscles, eventually causing 
orofacial symptoms and dysfunction and impacting the health-related quality of life of the 
affected individuals [1, 3, 5-7]. In growing individuals, TMJ inflammation can also critically 
affect dentofacial growth and development [8-13]. The TMJ has an intra-articular 
mandibular growth site of crucial importance for normal mandibular growth and 
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development [14], and therefore is considered particularly vulnerable to TMJ arthritis. 
Arthritis-associated dentofacial growth disturbances are among the primary long-term 
concerns for patients with JIA and TMJ involvement [15], and the orofacial consequences of 
TMJ arthritis are well described in the literature [1-4, 6, 8, 11, 13, 16]. In spite of this 
knowledge, the most commonly used clinical tools to assess JIA disease activity and physical 
function including the JADAS 27, the CHAQ, and the JAMAR pay little specific attention to 
the TMJs during the general disease assessment of patients with JIA  [17-19].   
Treatment of TMJ arthritis-induced mandibular growth disturbances involves non-surgical 
orthopedic splints and surgical orthognathic or distraction osteogenesis procedures over a 
long period, involving substantial intervention, and requiring an interdisciplinary treatment 
approach [20-22]. Outcomes are dependent on early intervention initiation and excellent 
patient cooperation [22].  
Few prospective studies have elucidated the incidence rates of orofacial conditions in non-
selected JIA cohorts [7, 23]. The establishment of accurate population-based estimates of 
TMJ arthritis-related orofacial conditions and the identification of predictors for dentofacial 
deformities would improve risk assessment, family counseling, and the development of 
standardized interdisciplinary treatment approaches combining the efforts of pediatric 
rheumatologists, orthodontists, maxillofacial surgeons, and orofacial pain specialists.   
In this regional cohort study of growing patients, we aimed to estimate the cumulative 
incidences of patient-reported symptoms, clinical orofacial dysfunctions, and arthritis-
induced dentofacial deformity in JIA, and identify predictors for the development of 
arthritis-induced dentofacial deformities.  
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Patients and Methods 
Study design and population 
Data was retrieved from the Aarhus JIA TMJ cohort register, containing standardized 
longitudinal observational data on patients with JIA seen at the Regional Specialist 
Craniofacial Clinic, Section of Orthodontics, Aarhus University, Denmark between 1990 and 
May 2016. The vast majority of diagnosed patients with JIA are referred to the Regional 
Specialist Craniofacial Clinic for regular orofacial examinations and management of arthritis-
induced orofacial conditions by the pediatric rheumatology hospital centers of western 
Denmark. The Danish healthcare system is a public, tax-funded system in which decisions 
related to disease management are independent of financial and insurance status, which 
means that the Aarhus JIA TMJ cohort is representative of the overall JIA population in 
western Denmark. Patients with JIA are longitudinally followed at the Regional Specialist 
Craniofacial Clinic regardless of TMJ arthritis involvement. Orthodontists with specialized 
expertise conduct the clinical examinations, and all clinical visits are standardized in 
agreement with international consensus-based recommendations for orofacial examination 
for JIA and include a 57-items standardized orofacial examination procedure [24]. 
Data was retrieved from the register using the following inclusion criteria: 1) JIA diagnosis 
according to ILAR criteria [25], 2) less than 14 years of age at first visit, to ensure remaining 
potential for dentofacial growth, 3) First clinical visit in 2000 or later, 4) A minimum of 3 
years of observation time with a minimum of one clinical orofacial examination per year. 
The study was approved by the Danish Health and Medicine Authorities (3-3013-1803/1/) 
and the Danish Data Protection Agency (1-16-02-500-16).  
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Assessments 
The following background information was retrieved from the referring hospital charts: Age 
at JIA onset, JIA subcategory, total number of active joints at diagnosis, antinuclear antibody 
(ANA), rheumatoid factor (RF), medication history, and remission on/off medication at last 
follow-up according to the 2004 preliminary Wallace criteria (See online Supplementary 
Table S1) [26]. Subjects with a final follow-up visit before 2004, were classified 
retrospectively according to the classifications by Petty et al. and the Wallace et al. after 
2004 [25, 26].  
The following information about first patient-reported orofacial symptoms was retrieved 
from the register. Orofacial symptoms were defined as the first patient or parent report of 
any of the following: TMJ sounds (crepitation/clicking), TMJ pain, pain from masticatory 
muscles, TMJ morning stiffness, and reduced chewing function. Information about the first 
abnormal examination finding of orofacial dysfunction was retrieved from the register. 
Orofacial dysfunction was defined as the first detection of any of the following signs by a 
qualified orthodontist performing a standardized orofacial exam: TMJ pain on palpation, 
masticatory muscle pain on palpation, asymmetric mouth opening, reduced maximal mouth 
opening compared to age-related non-JIA normative values [27], and TMJ sounds during 
clinical examination (crepitation/clicking) (for details see online supplementary figure S1). 
No standardized clinical criteria exist for the definition of arthritis-induced dentofacial 
deformity, therefore, in the present study, we defined dentofacial deformity as follows: 
“Patients with clinical and radiological findings documenting arthritis-induced TMJ deformity 
and incipient dentofacial deformity, beyond normal variation, requiring orthodpedic 
treatment with dental splint. Orthopedic treatment with a non-surgical orthopedic 
functional appliance (distraction splint) was initiated following the diagnosis of dentofacial 
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deformity. Diagnosis and treatment decisions related to dentofacial deformity were based 
on clinical findings and guided by radiological findings of TMJ pathology, using 3-
dimensional (3D) cone beam computerized tomography scan (CBCT) techniques to assess 
the severity of the dentofacial deformity [28].  
The definitions of TMJ symptoms, TMJ dysfunction, and dentofacial deformity adhere to the 
Temporomandibular Joint Juvenile Arthritis Work group (TMJaw) consensus-based 
standardized terminology [29] 
 
Statistics 
Descriptive statistics of the median, first, and third quartiles were applied to assess age at 
first orofacial examination and time span between JIA disease onset and first clinical visit at 
the Craniofacial clinic. Kaplan-Meier estimates were performed to describe the cumulative 
incidences of patient-reported orofacial symptoms, orofacial dysfunction, and dentofacial 
deformity from the first clinical visit and the following 36 months for the total cohort and for 
the subcategories. First orofacial symptom was defined as the first date any orofacial 
symptom was reported during the clinical orofacial examination (including TMJ sounds, TMJ 
pain, pain from masticatory muscles, TMJ stiffness, and reduced chewing function). First 
orofacial sign was defined as the first date any orofacial dysfunction occurred during clinical 
orofacial examination (including TMJ pain on palpation, masticatory muscle pain on 
palpation, asymmetric mouth opening, reduced maximal mouth opening, and TMJ sounds). 
The event date of dentofacial deformity was defined as the date that treatment with a 
functional orthopedic appliance was initiated. The first clinical visitation was defined as the 
event date in cases for which an event was already present. Censor time was 36 months 
after the date of the first clinical visit. Cox proportional hazard analysis was conducted to 
This article is protected by copyright. All rights reserved. 
assess the association between predefined candidate parameters and the diagnosis of 
dentofacial growth deviation. All candidate parameters were dichotomized, and hazard 
ratios were calculated by univariate Cox proportional hazard analyses. Parameters with 
statistically significant outcomes in the univariate analyses were included in a multivariate 
Cox proportional hazard analysis for calculation of adjusted hazard ratios. The level of 
significance was p<0.05.  
 
Results 
The Aarhus JIA TMJ cohort consisted of 1040 subjects with JIA in May 2016. 351 subjects 
(33.7%) met the predefined inclusion criteria (Figure S2). Reasons for exclusion were: first 
visitation before 2000 (n=70), ≥14 years of age at first orofacial examination (n= 168), no 
initial examination at first visit (n=17), other reasons (n=27), less than three examinations 
(n=307), less than 36 months total follow-up (n=83), three examinations more than 12 
months apart (n=17).  The most common reason for exclusion was less than three years of 
follow-up. The median time between JIA onset and first orofacial clinical examination was 
668 days (25 and 75 centiles: 364 days and 1026 days), and median age at first clinical visit 
at the Craniofacial Clinic was 6.6 years (25 and 75 centiles: 4.9 years and 9.9 years). All JIA 
subcategories were represented in the study-cohort, including systemic JIA (n=19), oligo 
persistent JIA (n=137), oligo extended JIA (n=69), polyarticular RF-negative (n=80), 
polyarticular RF-positive (n=7), psoriatic arthritis (n=15), enthesitis related arthritis (n=16), 
and undifferentiated arthritis (n=8). Cohort characteristics are described in Table 1. 70.1 
percent of the included subjects were females. 
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The secondary excluded subjects (n=407, Figure S2) were significantly older than the 
included subjects (Median: 9.5 years, 25 and 75 centiles: 5.6 and 11.9 years). The group of 
excluded subjects was comparable to the study cohort in terms of JIA category distribution 
and male/female ratio.   
 
Orofacial symptoms 
Twenty-five percent of the included subjects reported at least one symptom at the first 
clinical visit (Figure 1a, table 2), and the cumulative incidence of orofacial symptoms 
reached 38% at the 36-month follow-up, corresponding to an annual incidence of 4.3% from 
the clinical baseline visit. Substantial variations in the cumulative incidences of orofacial 
symptoms were observed between JIA subcategories at the 36-month follow-up, varying 
from 21% to 62% (Figure 1.b, Table 2). At the 36-month follow-up, the highest and the 
lowest incidences of orofacial symptoms were seen in the undifferentiated (62%) and 
systemic subcategories (21%). The most frequently reported orofacial symptoms were TMJ 
pain (25.1%), chewing limitation (20.5%), and TMJ sounds (14.2%) (Table 3). Symptomatic 
patients presented variable numbers of symptoms over the 36 months of observation, and 
the presence of multiple symptoms was rare. Most symptomatic subjects reported one 
(16.5%) or two symptoms (9.4%) over the 36 months of observation.  
 
Orofacial dysfunction 
Thirty-six percent of the total cohort had at least one clinical sign of orofacial dysfunction at 
the first clinical visit (Figure 1c, Table 2). The cumulative incidence increased to 53% at the 
36-month follow-up, corresponding to an annual  incidence of 6.7% from the baseline 
orofacial examination. Substantial variations in the cumulative incidences of orofacial 
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dysfunctions were observed between JIA subcategories at the 36-month follow-up, varying 
from 27% to 75% (Figure 1.d, Table 2). The highest and the lowest incidences of orofacial 
dysfunction were seen in the enthesitis-related (75%) and psoriatic arthritis (27%) 
subgroups. The most frequent orofacial dysfunctions were asymmetric mouth opening 
(25.1%) and muscular pain on palpation (21.7%) (Table 3), and the number of clinical signs 
of orofacial dysfunction also varied among the subjects over the 36 months of observation. 
The presence of > 2 signs of orofacial dysfunction was rare (Table 3). 
 
Arthritis-induced dentofacial deformity  
Two percent of the subjects had already received orthodontic/orthopedic treatment for 
dentofacial deformity at the first clinical visit (Figure 2a, Table 2), and the cumulative 
incidence of subjects receiving treatment for arthritis-induced dentofacial deformity 
increased in a non-linear fashion to 35% at the 36-month follow-up. Substantial variations in 
cumulative incidences of dentofacial deformity were observed between JIA subcategories at 
the 36-month follow-up, varying from 0% to 51% (Figure 2b, Table 2). The highest and 
lowest follow-up subcategory incidences of dentofacial deformity were seen in the 
polyarticular RF-negative JIA subgroup (51%) and in the polyarticular RF-positive JIA 
subgroup (0%).  
 
Association between subject characteristics and dentofacial deformity 
The following characteristics were significantly associated with the risk of dentofacial 
deformity in the univariate Cox proportional hazard analysis (Table 4): A) The presence of 
orofacial symptoms at the baseline orofacial examination (Odds ratio [OR]): 2.22, 95% 
confidence interval (CI): 1.45-3.41. B) The presence of orofacial dysfunctions at the baseline 
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orofacial examination (OR: 3.28, CI: 2.23-4.83). Only the presence of orofacial dysfunctions 
at the baseline orofacial examination was significantly associated with dentofacial deformity 
in the multivariate hazard analysis (OR: 1.86, CI: 1.24-2.8) (Table 4).  
 
Discussion 
To date this is the largest study to investigate the orofacial complications to JIA. This study 
demonstrates that orofacial symptoms and dysfunction are common features and 
characteristics 36 months after the first clinical examination and approximately five years 
after JIA onset, with cumulative incidences of 38% and 53% respectively. Orofacial 
symptoms and dysfunction are present in all JIA subcategories, and dentofacial deformity 
occurs in one third of subjects at the 36 month follow-up, approximately five years after JIA 
onset. These findings represent new and important insights into the prevalence of orofacial 
complications in growing subjects with JIA.  
Previous cross-sectional and longitudinal observational studies have consistently reported 
the presence of TMJ arthritis in a substantial proportion of children and adolescents with JIA 
[1, 3, 7]. However, prior studies have also implied that JIA-induced orofacial symptoms and 
dysfunction are rare in young individuals with recent JIA onset. Olson et al. reported that 
symptoms of dysfunction were almost absent in subjects younger than seven years in a 
cross-sectional study [30].  In 2008, Weiss et al. demonstrated that TMJ arthritis was present 
in the majority of patients with new-onset JIA (median age 8.6 years), despite the fact that 
71% were asymptomatic [4]. The findings in the present study conflict with these previous 
findings and indicate a high incidence of orofacial complications in children in a JIA cohort 
with a median age of 6.6 years at first orofacial examination. The multivariate cox 
proportional analysis showed a significant association only between clinical orofacial 
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dysfunction and dentofacial deformity underlining the unpredictable nature of the arthritis-
induced growth deviations that can occur in all JIA subcategories. It is noteworthy that age 
at onset, number of involved joints at diagnosis, and biological prescription were not 
significantly associated with the presence of dentofacial deformity. It is also noteworthy 
that a small proportion of subjects diagnosed with dentofacial deformity presented isolated 
TMJ arthritis with no other involved joints at onset, as recently described by Hügle et al. 
[31]. This specific group was characterized by a longstanding and complex course before JIA 
diagnosis was established.  
 
Clinical aspects 
The cumulative incidences reported in this study can be used to approximate the general 
risk of orofacial complications within all JIA subcategories. We recognize, that not all kinds 
of orofacial symptoms and dysfunctions necessarily require active disease treatment, nor 
has a significant impact on health. However, the reported incidences underline that clinical 
orofacial examination is an essential element in the general health assessment of individuals 
diagnosed with JIA, regardless of JIA subcategory. Contrast-enhanced magnetic resonance 
imaging (MRI) is the gold standard for TMJ arthritis diagnosis, and previous studies have 
shown that clinical orofacial examination has a low sensitivity for diagnosis of TMJ arthritis 
[16]. However, the standardized orofacial examination serves three additional and 
important purposes: 1) Standardized routine orofacial examination provide a solid basis for 
the general assessment of dentofacial growth and development, when sudden onset of 
orofacial symptoms, alterations in TMJ function, and/or development of dentofacial 
deformity should prompt increased attention and appropriate referral of the patient for 
further clinical and radiological orofacial examinations, 2) It enables the diagnosis of TMJ 
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arthritis-induced orofacial symptoms, dysfunction, and growth deviations in previously 
asymptomatic subjects, and 3) It allows for the assessment of dentofacial growth and 
development and the progression of symptoms and dysfunction in subjects who were 
diagnosed with TMJ involvement. These complications may occur as a consequence of 
previous TMJ arthritis and are not always associated with the presence of MRI findings of 
active TMJ inflammation.  
Recently, international, multidisciplinary, consensus-based recommendations have 
highlighted important aspects for inclusion in the orofacial examination of subjects with JIA 
within each of the following domains: background information and general disease history, 
orofacial symptoms, masticatory muscle and temporomandibular joint function, and 
orofacial function and dentofacial growth [24]. An international multidisciplinary task force 
under the TMJaw network is currently validating a standardized patient symptom 
questionnaire and a 3-minute clinical examination protocol exclusively for JIA. 
 
Strengths  
Strengths of the present study include: 1) The distribution of the different JIA subcategories 
in our study cohort is comparable to previous population-based studies in the Scandinavian 
JIA population and comparable to the group of excluded subjects from the Aarhus TMJ 
register [32]. 2) The inclusion of subjects from the large non-selected Aarhus JIA TMJ cohort 
that represents the JIA population of western Denmark. Orofacial examination and 
treatment is an integrated part of the pediatric rheumatology care offered to Danish 
patients with JIA – regardless of financial or insurance status.  According to the Danish 
Rheumatism Association [33], approximately 1200 children (<16 years) in Denmark have a 
diagnosis of JIA; when including subjects >16 years, approximately 2000 subjects in 
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Denmark are diagnosed with JIA. Demographically, approximately 60 percent of total JIA 
population are assigned for orofacial examination at the Western Regional Specialist 
Craniofacial Clinic. In May 2016, the Aarhus TMJ arthritis cohort consisted of 1040 subjects 
which approximate the 60 percent of the total Danish JIA population. 3) The routine 
examination regime for all cohort subjects, regardless of the presence of TMJ involvement. 
4) The use of orofacial examination standards in agreement with consensus-based 
recommendations conducted by specially trained orthodontists. The consensus-based 
recommendations on clinical orofacial examination were published in 2017 [24].  These JIA-
specific recommendations comply with historical recommendations for clinical orofacial 
examination in subjects with temporomandibular disorders and those recommendations 
still constitute the scientific foundation for contemporary assessment of orofacial symptoms 
and dysfunction [34, 35]. We consider it a strength to the present study, that all subjects 
received the exact same orofacial examination which means that subjects included before 
2017 received a standardized orofacial examination complying with the 2017 JIA-specific 
recommendations.  
 
Limitations 
Attrition is a general limitation to the present study where 66 % (n=689) of the total JIA TMJ 
cohort was excluded due to strict inclusion criteria. During the secondary exclusion (S2), 
most of the subjects were excluded due to follow-up issues. The fact that the excluded 
subjects were approximately three years older at first examination, than the included study 
cohort, could introduce a bias to the presented results. It could be argued, that the high 
degree of exclusion due to follow-up issues could impact the results with an 
overrepresentation of subjects with symptoms, dysfunctions and deformities. An argument 
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against this is, that JIA-induced orofacial symptoms and dysfunctions occur more often 
during the teenage years similar to general TMD conditions in a non-JIA population 
[30,36,37]. According to a longitudinal study by Fjeld et al. 2009, the JIA-specific dentofacial 
deformities are established between 9 and 12 years of age during the dentofacial growth 
spurt [11]. The higher age at first visitation of the excluded subjects (9.5 years) favors a 
hypothesis, that an even greater proportion of the excluded subjects could present 
dentofacial deformities during a 36 months follow-up than the included study cohort with a 
median age of 6.6 years at first examination. According to Fjeld et al., JIA-specific 
dentofacial growth abnormalities does not develop to a significant degree between six to 
nine years of age when compared to a non-JIA control group [11].  
We recognize that the delay of 668 days between JIA onset and the first clinical orofacial 
examination is a limitation to findings of this study. Another limitation is the fact that some 
of the subcategories includes a limited amount of subjects representing a risk of bias to the 
reported incidences. Temporomandibular joint arthritis is a sub-diagnosis of the more 
general temporomandibular disorder (TMD), seen in 7-12% of the population without a JIA 
background [36, 37]. TMD is considered to be a multifactorial condition encompassing both 
degenerative, congenital, functional, and autoimmune etiologies [38, 39]. A limitation of the 
present study is the fact that no diagnostic methods exists to distinguish between JIA-
related orofacial symptoms and dysfunction and other TMD-related etiologies. This may 
only introduce a minor bias to our findings however, since TMD-related orofacial symptoms 
and dysfunction are most often observed in the late teenage population and infrequently in 
the age group examined in this study [36]. Another limitation of this study is the lack of 
standardized clinical definitions of dentofacial growth deviations. Since minor dentofacial 
deformity, such as dentofacial asymmetry, is a relatively common finding in a 7-year-old 
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non-JIA population [40], one may question whether the reported 35% cumulative incidence 
of dentofacial deformity could represent normal variation in non-JIA individuals. In this 
study, the term dentofacial deformity refers only to the proportion of the cohort receiving 
orthopedic appliance treatment for a deviating dentofacial growth pattern. The decision to 
initiate orthopedic appliance treatment was guided by clinical orofacial dysfunctional 
findings and CBCT evidence of TMJ and dentofacial deformity, and we feel confident that 
this 35% represents patients with arthritis-induced dentofacial deformity. We initiated early 
application of orthopedic treatment as soon as radiological evidence of TMJ deformity 
and/or dentofacial deformity occurred, according to standard procedure. We have 
previously shown the clinical merits of the early application of orthopedic splint treatment 
in 7-year-old subjects with unilateral TMJ arthritis-induced dentofacial deformity, and find it 
unethical to postpone initiation of treatment until dentofacial deformity becomes more 
severe [22].   
It is important to recognize that only subjects less than 14 years of age were included, in 
order to assess dentofacial deformity among growing subjects when interpreting our 
results. Therefore, our results cannot be extrapolated to the entire JIA population, with an 
age range between 0-16 years. We hypothesize that the relative population-based incidence 
of dentofacial deformity would be slightly lower if non-growing 14 to 16 year old subjects 
had also been included, since late JIA onset rarely leads to dentofacial growth deviation 
requiring orthopedic treatment. Future population-based research is needed to clarify this 
issue.   
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Recently, important progress has been made in the management of TMJ arthritis and the 
related orofacial complications of JIA: 1) Consensus-based recommendations have been 
published for clinical orofacial examination of patients with JIA [24]. 2) A consensus-based 
MRI scoring system has been developed [41, 42] with additional proposals for an objectively 
reliable way to quantify TMJ synovial enhancement [43]. 3) Reliable and valid 3D 
morphometric measures have been proposed to assess dentofacial deformity [28]. 4) 
Concerns have been raised regarding the use of intra-articular TMJ steroid injections for TMJ 
arthritis in growing individuals, due to relatively low long-term effects on inflammation and 
marked risk for side-effects [44-46].  We believe that the findings presented here will 
further aid the management of TMJ arthritis, enabling risk assessment of orofacial 
complication to JIA. In conclusion, we found substantial cumulative incidences of orofacial 
symptoms and orofacial dysfunctions at a 36-month follow-up, and it is noteworthy that 
approximately one-third of these patients had arthritis-induced dentofacial deformity 
associated only with the presence of orofacial dysfunction.    
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Table 1. Cohort characteristics. * From diagnosis of JIA to 3 years after first orofacial examination. 
**intra-articular steroid injection in any joint from JIA diagnosis to 3 years after first orofacial 
examination. *** Remission status 3 years after first orofacial examination. Abbreviation: Poly RF-; 
Polyarticular rheuma factor negative. Poly RF+; Polyarticular rheuma factor positive. ERA: enthesitis 
related arthritis. Undiff.: undifferentiated arthritis.  TNF-a: Tumor necrosis alpha. IA: intra-articular. 
 
 
 
 
Total 
cohort  
 (n=351) 
Systemic 
JIA 
(n=19) 
Oligo 
persistent 
JIA 
(n=136) 
Oligo 
extended JIA 
(n= 69) 
Poly RF-  
JIA 
(n=80) 
Poly RF+  
JIA (n=7) 
Psoriatic JIA 
(n=15) 
ERA 
(n=16) 
Undiff. JIA 
(n=8) 
Age at JIA onset 
(median years & 
1st/3rd quartile) 
4.6  
(2.1-8.1) 
6.4  
(3.1-7) 
4.1  
(2-7.7) 
2.9  
(1.9-5.2) 
4.8  
(2.4-8.2) 
8.5 
(4.7-10.7) 
7.1 
(3.4-9.3) 
8.2  
(6.9-9) 
7.2 
(6.4-10) 
Age at first clinical 
orofacial exam. (median 
years & 1st/3rd 
quartile) 
6.6  
(4.8-9.9) 
7.5 
(5.1-8.4) 
     
 
6.5 
(4.6-9.9) 
5.6 
(4.3-8.5) 
6.6  
(4.9-9.3) 
10.6  
(8.5-11.6) 
9.2 
 (5.9-10.9) 
10.1  
(8.5-10.5) 
10.5  
(8-12.2) 
Age at JIA onset < 9 
years (%) 
287 (81.8) 18 (94.7) 111 (81) 62 (89.9) 65 (81.2) 4 (57.1) 10 (66.7) 12 (75) 5 (62.5) 
ANA positive (%) 145 (41.3) 2 (10.5) 58 (42.3) 38 (55.1) 37 (46.2) 2 (28.6) 3 (20) 2 (12.5) 3 (37.5) 
Methotrexate user (%)* 218 (62.1) 12 (63.2) 55 (40.1) 44 (63.8) 71 (88.8) 6 (85.7) 11 (73.3) 12 (75) 7 (87.5) 
TNF-a user (%)* 88 (25.1) 5 (26.3) 16 (11.7) 14 (20.3) 30 (37.5) 6 (85.7) 5 (33.3) 10 (62.5) 2 (25) 
IA. Steroid (not only 
TMJ) */** 
 
322 (91.7) 14 (73.7) 122 (89.1) 68 (98.6) 78 (97.5) 7 (100) 13 (86.7) 12 (75) 8 (100) 
Prednisolon user (%)* 
 
51 (14.5) 16 (84.2) 10 (7.3)  
  
8 (11.6) 10 (12.5) 0 (0) 3 (20) 4 (25) 0 (0) 
Active joint count at 
diagnosis >4 joints (%) 
 
70 (19.9) 3 (15.8) 0 (0) 0 (0) 52 (65) 6 (85.7) 2 (13.3) 2 (12.5) 4 (50) 
Remission on 
medication > 6 
months*** 
 
90 (25.6) 7 (36.8) 19 (13.9) 22 (31.9) 29 (36.2) 5 (71.4) 3 (20) 3 (18.8) 2 (25) 
Remission off 
medication > 12 
months*** 
137 (39) 7 (36.8) 74 (54) 18 (26.1) 20 (25) 0 (0) 7 (46.7) 6 (37.5) 5 (62.5) 
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Table 2. Cumulative incidence of orofacial symptoms, orofacial dysfunction, and dentofacial 
deformity in subjects with JIA within the 36 months after first orofacial examination. *351 subjects 
were included, but one subject had started treatment for dentofacial deformity before first clinical 
visit. 
 First visit 
0 Months 
12 
Months 
24 
Months 
36 
Months 
n Events within 
 first 36 months 
Orofacial 
symptom  
      
Total cohort 0.25  (0.20-0.29) 0.29 (0.24- 0.34) 0.33 (0.28-0.38) 0.38 (0.33-0.43) 351 133 
Systemic  0.16 (0.00-0.31) 0.16 (0.00-0.31) 0.21 (0.00-0.37) 0.21 (0.00-0.37) 19 4 
Oligo pers. 0.18 (0.11-0.24) 0.23 (0.15-0.30) 0.26 (0.19-0.34) 0.32 (0.23-0.39) 136 43 
Oligo ext. 0.26 (0.15-0.36) 0.29 (0.17-0.39) 0.33 (0.21-0.44) 0.38 (0.25-0.48) 69 26 
Poly RF neg. 0.32 (0.21-0.42) 0.35 (0.24-0.45) 0.39 (0.27-0.49) 0.46 (0.34-0.56) 80 37 
Poly RF pos. 0.29 (0.00-0.55) 0.43 (0.00-0.70) 0.43 (0.00-0.70) 0.43 (0.00-0.70) 7 3 
PsA 0.20 (0.00-0.38) 0.33 (0.05-0.53) 0.40 (0.09-0.60) 0.47 (0.14-0.67) 15 7 
ERA 0.44 (0.13-0.63) 0.50 (0.18-0.69) 0.50 (0.18-0.69) 0.50 (0.18-0.69) 16 8 
Undiff. 0.62 (0.08-0.85) 0.62 (0.08-0.85) 0.62 (0.08-0.85) 0.62 (0.08-0.85)  8 5 
 
Orofacial 
dysfunction 
      
Total cohort 0.36 (0.31-0.41) 0.42 (0.36-0.47) 0.48 (0.42-0.53) 0.53 (0.48-0.58) 351 186 
Systemic  0.21 (0.00-0.37) 0.32 (0.07-0.50) 0.42 (0.15-0.61) 0.42 (0.15-0.61) 19 8 
Oligo pers. 0.34 (0.26-0.42) 0.39 (0.30-0.46) 0.43 (0.34-0.51) 0.49 (0.40-0.57) 136 67 
Oligo ext. 0.39 (0.26-0.50) 0.41 (0.28-0.51) 0.48 (0.35-0.58) 0.54 (0.40-0.64) 69 37 
Poly RF neg. 0.36 (0.25-0.46) 0.47 (0.35-0.57) 0.58 (0.45-0.67) 0.64 (0.52-0.73) 80 51 
Poly RF pos. 0.14 (0.00-0.37) 0.29 (0.00-0.55) 0.29 (0.00-0.55) 0.29 (0.00-0.55) 7 2 
PsA 0.20 (0.00-0.38) 0.27 (0.00-0.46) 0.27 (0.00-0.46) 0.27 (0.00-0.46) 15 4 
ERA 0.62 (0.29-0.80) 0.62 (0.29-0.80) 0.69 (0.35-0.85) 0.75 (0.42-0.89) 16 12 
Undiff. 0.62 (0.08-0.85) 0.62 (0.08-0.85) 0.62 (0.08-0.85) 0.62 (0.08-0.85) 8 5 
 
Dentofacial 
deformity 
      
Total cohort 0.02 (0.01-0.03) 0.24 (0.20-0.29) 0.32 (0.27-0.37) 0.35 (0.30-0.40) 350* 123 
Systemic  0.00 (0.00-0.00) 0.11 (0.00-0.23) 0.11 (0.00-0.23) 0.16 (0.00-0.31) 19 3 
Oligo pers. 0.03 (0.00-0.06) 0.21 (0.14-0.28) 0.24 (0.17-0.31) 0.28 (0.20-0.35) 136 39 
Oligo ext. 0.00 (0.00-0.00) 0.26 (0.15-0.36) 0.39 (0.26-0.50) 0.41 (0.28-0.51) 69 28 
Poly RF neg. 0.01 (0.00-0.04) 0.32 (0.21-0.42) 0.48 (0.35-0.57) 0.51 (0.39-0.61) 80 41 
Poly RF pos. 0.00 (0.00-0.00) 0.00 (0.00-0.00) 0.00 (0.00-0.00) 0.00 (0.00-0.00) 7 0 
PsA 0.07 (0.00-0.18) 0.20 (0.00-0.38) 0.33 (0.05-0.53) 0.33 (0.05-0.53) 15 5 
ERA 0.00 (0.00-0.00) 0.19 (0.00-0.36) 0.19 (0.00-0.36) 0.19 (0.00-0.36) 16 3 
Undiff. 0.12 (0.00-0.33) 0.50 (0.00-0.75) 0.50 (0.00-0.75) 0.50 (0.00-0.75) 8 4 
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Table 3. Relative prevalence of individual events and number of unique events within the first 36 
months. *Two standard deviations below age-related normative values. TMJ; Temporomandibular 
joint. 
 Relative prevalence of 
individual events within 
the first 36 months (%) 
Prevalence of orofacial symptoms   
TMJ Sounds 14.2% 
TMJ pain  25.1% 
TMJ stiffness 10.6% 
Muscle pain 6.0% 
Chewing limitation 20.5% 
  
Number of symptoms (per subject)  
None 62% (n=218) 
1 16.5% (n=58) 
2 9.4% (n=33) 
3 7.4% (n=26) 
4 4% (n=14) 
5 0.6% (n=2) 
  
Prevalence of orofacial dysfunctions  
Reduced maximal incisal opening* 10.0% 
Asymmetric mouth opening 25.1% 
TMJ pain on palpation 15.4% 
Muscular pain on palpation 21.7% 
TMJ sounds 16.0% 
  
Number of dysfunctions (per subject)  
None 47% (n=165) 
1 29.9% (n=105) 
2 13.4% (n=47) 
3 7.4% (n=26) 
4 2.3% (n=8) 
 
 
 
 
Table 4. Association between orofacial symptoms, orofacial signs, subject characteristics and the 
development of dentofacial deformity within three years after baseline orofacial examination. 
Dentofacial deformity is defined as the need for orthopedic intervention. *Represent events 
identified during the baseline orofacial examination.   
 
 Univariate crude 
hazard ratio (95% 
CI) 
P value Multivariate crude 
hazard ratio (95% CI) 
Adjusted P-
value 
Subjects with 
feature 
Orofacial symptoms* 2.22 (1.45-3.41) 0.0002 1.4 (0.89-2.2) 0.14 30* 
Orofacial dysfunction* 3.28 (2.23-4.83) 0.0000 1.86 (1.24-2.8) 0.003 45* 
Age at debut > 9 years 1.18 (0.76-1.84) 0.47 - - 64 
ANA positive 1.4 (0.98-2.00) 0.07 - - 145 
Active joint count at diagnosis > 4 joins 1.42 (0.94-2.14) 0.1 - - 70 
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Legends 
 
Figure 1. Cumulative incidences of first orofacial symptoms and first orofacial dysfunction within the 
36 months following first clinical orofacial examination. a) First orofacial symptom in the total 
cohort, b) first orofacial symptom within JIA subcategories, c) first orofacial dysfunction in the total 
cohort, d) first orofacial dysfunction within JIA subcategories. Dotted lines in figure 2a, 2c represent 
the 95% confidence intervals. 
 
Figure 2. Cumulative incidence of dentofacial deformity within the 36 months following first clinical 
orofacial examination. a) Within the total cohort. b) Dentofacial deformity within JIA subcategories.  
Dotted lines in figure 3a represent the 95% confidence intervals. 
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